FdaApplication
BLA 103976
Identifiers
- fda_app_no: BLA103976
Properties
| Property | Value |
|---|---|
| applicant_name | Genentech, Inc. |
| application_type | BLA |
| approval_date | 2003-06-20 |
Products (7)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XOLAIR | OMALIZUMAB | 150MG | For Injection |
| XOLAIR | OMALIZUMAB | 75MG/0.5ML | Injection |
| XOLAIR | OMALIZUMAB | 300MG/2ML | Injection |
| XOLAIR | OMALIZUMAB | 150MG/ML | Injection |
| XOLAIR | — | 300MG/2ML | Injection |
| XOLAIR | — | 75MG/0.5ML | Injection |
| XOLAIR | — | 150MG/ML | Injection |
7 products